By vgreene, 18 February, 2020 Reassess individualize glycemic targets over time based on modifiable non modifiable pt dz features2 3 E
By vgreene, 18 February, 2020 If pt has established atherosclerotic CV dz or indicators of high risk, established kidney dz, or HF, an SGLT-2 inhibitor or GLP-1 RA w/ demonstrated CV dz benefit is recommended as part of tx regimen independent of A1C [A]
By vgreene, 18 February, 2020 In pts who need greater glucose lowering than can be obtained w/ oral agents, GLP-1 RAs are preferred to insulin when possible [B]
By vgreene, 18 February, 2020 DM self-mgmt education/support programs may be appropriate in order to develop/maintain behaviors that can prevent/delay development of T2DM [B]
By vgreene, 18 February, 2020 Variety of eating patterns acceptable for pts w/ prediabetes [B], incl Mediterranean and low-cal, low-fat diets